CLDX - Celldex Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLDX is currently covered by 6 analysts with an average price target of $99.24. This is a potential upside of $62.94 (173.39%) from yesterday's end of day stock price of $36.3.

Celldex Therapeutics's activity chart (see below) currently has 45 price targets and 60 ratings on display. The stock rating distribution of CLDX is 90.48% BUY, 4.76% SELL and 4.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.34% with an average time for these price targets to be met of 54.73 days.

Highest price target for CLDX is $90, Lowest price target is $27, average price target is $99.24.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 27-Feb-2024. First documented stock forecast 19-Dec-2008.

Currently out of the existing stock ratings of CLDX, 19 are a BUY (90.48%), 1 are a SELL (4.76%), 1 are a HOLD (4.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$52.98 (143.11%)

72

2 months 2 days ago

0/4 (0%)

$38.96 (76.33%)

Hold

27

$-10.02 (-27.07%)

21

5 months 19 days ago

1/2 (50%)

$0.06 (0.22%)

4

Buy

80

$42.98 (116.10%)

73

5 months 23 days ago

6/15 (40%)

$50.65 (172.57%)

256

Buy

52

$14.98 (40.46%)

54

5 months 26 days ago

4/11 (36.36%)

$26.02 (100.15%)

62

Buy

68

$30.98 (83.68%)

70

8 months 18 days ago

0/3 (0%)

$37.77 (124.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLDX (Celldex Therapeutics) average time for price targets to be met?

On average it took 54.73 days on average for the stock forecasts to be realized with a an average price target met ratio 21.34

Which analyst has the current highest performing score on CLDX (Celldex Therapeutics) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on CLDX (Celldex Therapeutics)?

Biren Amin has 4 price targets and 4 ratings on CLDX

Which analyst is the currently most bullish on CLDX (Celldex Therapeutics)?

Jonathan Aschoff with highest potential upside - $437.48

Which analyst is the currently most reserved on CLDX (Celldex Therapeutics)?

Mara Goldstein with lowest potential downside - -$34.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?